The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro
Open accessAbstract
We have found that the ubiquitin-proteasome pathway exerts exquisite control of osteoblast differentiation and bone formation in vitro and in vivo in rodents. Structurally different inhibitors that bind to specific catalytic beta subunits of the 20S proteasome stimulated bone formation in bone organ cultures in concentrations as low as 10 nM. When administered systemically to mice, the proteasome inhibitors epoxomicin and proteasome inhibitor-1 increased bone volume and bone formation rates over 70% after only 5 days of treatment. Since the ubiquitin-proteasome pathway has been shown to modulate expression of the Drosophila homologue of the bone morphogenetic protein-2 and -4 (BMP-2 and BMP-4) genes, we examined the effects of noggin, an endogenous inhibitor of BMP-2 and BMP-4 on bone formation stimulated by these compounds and found that it was abrogated. These compounds increased BMP-2 but not BMP-4 or BMP-6 mRNA expression in osteoblastic cells, suggesting that BMP-2 was responsible for the observed bone formation that was inhibited by noggin. We show proteasome inhibitors regulate BMP-2 gene expression at least in part through inhibiting the proteolytic processing of Gli3 protein. Our results suggest that the ubiquitin-proteasome machinery regulates osteoblast differentiation and bone formation and that inhibition of specific components of this system may be useful therapeutically in common diseases of bone loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,096
Stimulation of Bone Formation in Vitro and in Rodents by Statins
Mundy, G., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B., Zhao, M., & Gutierrez, G. (1999) · Science · doi:10.1126/science.286.5446.1946 · Cited by 1,774
Self-citationRegulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583 · cited 1×
“For example, the peptide aldehydes are substrate analogues and transition state inhibitors, whereas lactacystin is a natural product of actinomycetes that covalently modifies the active site threonine of the β subunit (34).”
BackgroundProteasome inhibitors: a novel class of potent and effective antitumor agents.
Adams, J., Palombella, V. J., Sausville, E. A., Johnson, J. I., Destree, A. T., Lazarus, D. D., Maas, J., Pien, C. S., Prakash, S., & Elliott, P. J. (1999) · PubMed · Cited by 1,477
Proteasome inhibitors: from research tools to drug candidates
Kisselev, A. F., & Goldberg, A. L. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00056-4 · Cited by 1,184
Smith, W. C., & Harland, R. M. (1992) · Cell · doi:10.1016/0092-8674(92)90316-5 · Cited by 1,178
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10403 · Cited by 920
Self-citationHauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E., & Klagsbrun, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67143-1 · Cited by 869
Noggin, Cartilage Morphogenesis, and Joint Formation in the Mammalian Skeleton
Brunet, L. J., McMahon, J. A., McMahon, A. P., & Harland, R. M. (1998) · Science · doi:10.1126/science.280.5368.1455 · Cited by 825
Hui, C.-C., & Joyner, A. L. (1993) · Nature Genetics · doi:10.1038/ng0393-241 · Cited by 706
Aza-Blanc, P., Ramírez-Weber, F.-A., Laget, M.-P., Schwartz, C., & Kornberg, T. B. (1997) · Cell · doi:10.1016/s0092-8674(00)80292-5 · Cited by 661
Sonic Hedgehog-induced Activation of the Gli1Promoter Is Mediated by GLI3
Dai, P., Akimaru, H., Tanaka, Y., Maekawa, T., Nakafuku, M., & Ishii, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8143 · Cited by 466
MHC-linked LMP gene products specifically alter peptidase activities of the proteasome
Driscoll, J., Brown, M. G., Finley, D., & Monaco, J. J. (1993) · Nature · doi:10.1038/365262a0 · Cited by 448
Transducing Hedgehog: the story so far
Ingham, P. W. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3505 · Cited by 436
Pfeilschifter, J., & Mundy, G. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2024 · Cited by 431
Self-citationMéthot, N., & Basler, K. (1999) · Cell · doi:10.1016/s0092-8674(00)80592-9 · Cited by 369
Rao, S., Porter, D. C., Chen, X., Herliczek, T., Lowe, M., & Keyomarsi, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7797 · Cited by 345
Chen, C.-H., von Kessler, D. P., Park, W., Wang, B., Ma, Y., & Beachy, P. A. (1999) · Cell · doi:10.1016/s0092-8674(00)81960-1 · Cited by 264
Sin, N., Kim, K. B., Elofsson, M., Meng, L., Auth, H., Kwok, B. H. B., & Crews, C. M. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00376-5 · Cited by 207
Self-citationGroll, M., Koguchi, Y., Huber, R., & Kohno, J. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4869 · Cited by 176
Eponemycin exerts its antitumor effect through the inhibition of proteasome function.
Meng, L., Kwok, B. H. B., Sin, N., & Crews, C. M. (1999) · PubMed · Cited by 172
Self-citationElofsson, M., Splittgerber, U., Myung, J., Mohan, R., & Crews, C. M. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80128-8 · Cited by 166
Self-citationGoldberg, A. L., Akopian, T. N., Kisselev, A. F., Lee, D. H., & Rohrwild, M. (1997) · PubMed · Cited by 141
The effects of cytokines and growth factors on osteoblastic cells
Mundy, G. R., Boyce, B. F., Hughes, D. E., Wright, K., Bonewald, L. F., Dallas, S. L., Harris, S., Ghosh‐Choudhury, N., Chen, D., Dunstan, C. R., et al. (1995) · Bone · doi:10.1016/8756-3282(95)00182-d · Cited by 137
Self-citationHarris, S. E., Sabatini, M., Harris, M. A., Feng, J. Q., Wozney, J. M., & Mundy, G. R. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090314 · Cited by 129
Self-citationDunstan, C. R., Boyce, R. W., Boyce, B. F., Garrett, I. R., Izbicka, E., Burgess, W. H., & Mundy, G. R. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.6.953 · Cited by 124
Self-citationMüller, B., & Basler, K. (2000) · Development · doi:10.1242/dev.127.14.2999 · Cited by 109
Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice
Ghosh‐Choudhury, N., Windle, J. J., Koop, B. A., Harris, M. A., Guerrero, D., Wozney, J. M., Mundy, G. R., & Harris, S. E. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536632 · Cited by 101
Self-citation5-Lipoxygenase Metabolites Inhibit Bone Formation in Vitro
Traianedes, K., Dallas, M. R., Garrett, I. R., et al. (1998) · Endocrinology · doi:10.1210/endo.139.7.6115 · Cited by 96
Self-citationHigh-Dose Estrogen Induces De Novo Medullary Bone Formation in Female Mice
Samuels, A., Perry, M. J., & Tobias, J. H. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.2.178 · Cited by 93
Cited by
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G., & Anderson, K. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2189 · Cited by 932
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Mechanisms of Anabolic Therapies for Osteoporosis
Canalis, E., Giustina, A., & Bilezikian, J. P. (2007) · New England Journal of Medicine · doi:10.1056/nejmra067395 · Cited by 668
Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
Kisselev, A. F., van der Linden, W. A., & Overkleeft, H. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.003 · Cited by 527
Metadata
- Authors
- Garrett, I. R., Chen, D., Gutierrez, G., Zhao, M., Escobedo, A., Rossini, G., Harris, S. E., Gallwitz, W., Kim, K. B., Hu, S., Crews, C. M., & Mundy, G. R.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-06-01
- Volume
- 111
- Issue
- 11
- Pages
- 1771-1782
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2108595411
- Cited by
- 328
- References
- 32
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.